Drug Testing for Special Government Employees Act
- Bill Number
- H.R. 2578
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Government Operations and Politics
- Status
- Introduced
- Latest Action
- 2025-04-01: Referred to the House Committee on Oversight and Government Reform.
- Last Updated
- 2026-02-04T04:26:31Z
AI-Generated Summary
Purpose
This legislation aims to enhance the integrity and security of federal government operations by requiring mandatory drug testing for special Government employees (SGEs)—temporary or part-time federal advisors or consultants—in sensitive positions. It ensures these individuals are free from controlled substances to maintain trust, safety, and national security.
Key Provisions
- Pre-Appointment Testing: Before starting service, prospective SGEs must undergo a drug test following the federal Mandatory Guidelines for Workplace Drug Testing Programs.
- Random Testing Program: Within 90 days of the bill's enactment, agencies must enroll current SGEs in sensitive positions into a random drug testing program under the same guidelines.
- Consequences of Positive Tests:
- Prospective SGEs testing positive for a controlled substance (e.g., illegal drugs like marijuana or cocaine, as defined in federal law) become ineligible for appointment for at least 12 months.
- Current SGEs testing positive must be removed from their position and barred from future SGE roles for at least 12 months.
- Definitions:
- Controlled substance: Any drug regulated under the federal Controlled Substances Act.
- Agency: Includes executive branch departments, the Executive Office of the President, and the Office of Management and Budget.
- Sensitive position: Roles involving access to classified information, impacts on safety or national security, or requiring high trust; also includes mission-critical duties.
- Special Government employee: Part-time or temporary federal workers serving no more than 130 days in a year, as defined in federal ethics law.
Significant Changes to Existing Law
This bill introduces new mandatory drug testing requirements specifically for SGEs, which were not previously required under federal workplace drug policies. While full-time federal employees in sensitive roles often face drug testing, SGEs (who provide expert advice on a short-term basis) have not been uniformly subject to these rules. It expands the scope of the Mandatory Guidelines for Federal Workplace Drug Testing Programs to cover this group.
Potential Impacts
- Government Agencies: Agencies must implement and fund testing programs, potentially increasing administrative costs and workload for hiring and oversight. This could streamline recruitment by disqualifying unfit candidates early but may limit the pool of available experts.
- Citizens: Indirectly benefits the public by promoting drug-free advisory roles in policy-making, enhancing government accountability and reducing risks in sensitive areas like national security. No direct impact on everyday citizens.
- International Relations: Minimal to none, as the bill focuses on domestic federal operations without addressing foreign policy or international personnel.
Main Stakeholders Affected
- Federal Agencies and Their Leaders: Responsible for conducting tests, managing programs, and enforcing penalties; includes a broad range of executive entities.
- Special Government Employees: Primarily experts, consultants, or advisors (e.g., scientists, lawyers, or industry professionals serving temporarily); they face new barriers to entry and retention if they use controlled substances.
- U.S. Government as a Whole: Affects advisory processes in areas like defense, health, and regulation, potentially influencing policy quality and public trust.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens enforcement of federal drug-free workplace standards by tying them explicitly to SGE eligibility, with clear penalties that could lead to administrative appeals or challenges under civil service laws.
- Constitutional: Drug testing in sensitive positions is generally upheld under the Fourth Amendment (protecting against unreasonable searches), as courts have ruled it justified for roles involving security or public safety; however, it may raise privacy concerns for non-security SGEs, potentially inviting lawsuits.
- Political: Promotes a stricter accountability framework for temporary government roles, aligning with broader anti-drug and ethics initiatives; it could spark debates on overreach into personal lives versus protecting national interests, but remains focused on high-trust positions without broader societal mandates.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Sherrill, Mikie [D-NJ-11]
Recent Actions
- 2025-04-01: Referred to the House Committee on Oversight and Government Reform.
- 2025-04-01: Introduced in House
- 2025-04-01: Introduced in House
Bill Versions
- Drug Testing for Special Government Employees Act — issued 2025-04-01 — PDF (3 pages)